Nearly 80 percent of organizations now use AI in at least one core business process, according to McKinsey, yet widespread adoption has surfaced a persistent problem: a deep shortage of professionals ...

As instigators of immunity, monoclonal antibodies are marvels of modern medicine, lab-made proteins that can treat cancers, autoimmune diseases, and many other conditions. With the market for these ...